Amnestix

Amnestix, Inc. is a biopharmaceutical company working on cognitive enhancement. The company focuses on novel therapeutics for improving

Amnestix, Inc. is a biopharmaceutical company working on cognitive enhancement. The company focuses on novel therapeutics for improving memory associated with a variety of human diseases. It also builds a pipeline of compounds, which are cognitive enhancers. The company was founded in 2006 and is based in Burlingame, California. As of June 8, 2008, Amnestix Inc. operates as a subsidiary of Sygnis Pharma AG.